PAR 1.69% 29.0¢ paradigm biopharmaceuticals limited..

Valuation and Targets, page-43

  1. 868 Posts.
    lightbulb Created with Sketch. 73
    the chances of becoming the next CSL are unfortunately unlikely as there it a strong chance that we go into partnership with a big pharma. who will provide the required funding going forward.
    I think that the partnership is a good result which will catapult the share price to a much higher level.
    I also think that Management is holding out as long as possible so to get the best deal for PAR. Good results from the US footballers will get us close to a partnership deal with big phara.
    I think that the timing for a partnership is about right at this point of the journey.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
29.0¢
Change
-0.005(1.69%)
Mkt cap ! $101.4M
Open High Low Value Volume
29.0¢ 29.3¢ 28.0¢ $57.32K 198.9K

Buyers (Bids)

No. Vol. Price($)
1 12454 28.5¢
 

Sellers (Offers)

Price($) Vol. No.
29.0¢ 4443 1
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.